Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Benoit_Woessmer
|
| gptkbp:foundedYear |
2017
|
| gptkbp:headquartersLocation |
gptkb:Paris,_France
|
| https://www.w3.org/2000/01/rdf-schema#label |
Curium Pharma
|
| gptkbp:industry |
radiopharmaceuticals
|
| gptkbp:numberOfEmployees |
over 2,000
|
| gptkbp:operatesIn |
gptkb:Asia
gptkb:Europe gptkb:North_America |
| gptkbp:origin |
merger of IBA Molecular and Mallinckrodt Nuclear Medicine
|
| gptkbp:parentCompany |
gptkb:CapVest_Partners_LLP
|
| gptkbp:products |
diagnostic imaging agents
therapeutic radiopharmaceuticals |
| gptkbp:serves |
nuclear medicine
|
| gptkbp:specializesIn |
PET radiopharmaceuticals
SPECT radiopharmaceuticals theranostics |
| gptkbp:website |
https://www.curiumpharma.com/
|
| gptkbp:bfsParent |
gptkb:CapVest_Partners_LLP
|
| gptkbp:bfsLayer |
7
|